Literature DB >> 9663600

Familial breast cancer in the family-cancer database.

K Hemminki1, P Vaittinen.   

Abstract

We use the population-based Family-Cancer Database from Sweden to study familial breast cancer. The size of the population and the nation-wide registration of cancer offer unique possibilities for epidemiological studies of familial cancer, including complete and unbiased identification of cases in the probands and in their relatives, and complete and unbiased identification of the family relationships. Using the Database, we wanted to answer the following questions: (i) proportion of familial breast cancer among all breast cancers; (ii) familial relative risks in breast cancer alone or in combination with another cancer, defined either through the mother or the daughter; (iii) modification of familial risk by age; and (iv) effects of paternal breast cancer alone or in combination with maternal breast cancer. The proportion of familial female breast cancer among all breast cancers before 54 years of age in Sweden was 8.7%. The familial relative risk was about 1.8, but is likely to decrease to about 1.5 in the ageing population. The higher familial relative risks were evident in young women, being 4.0 when both the mothers and their daughters were diagnosed at ages <40 years. Paternal breast cancer, in combination with maternal breast cancer, caused a large (but not statistically significant) risk in the daughters. In mothers and daughters, ovarian but not colon cancer was increased in combination with breast cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9663600     DOI: 10.1002/(sici)1097-0215(19980729)77:3<386::aid-ijc13>3.0.co;2-6

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

Review 1.  Polygenic susceptibility to breast cancer: current state-of-the-art.

Authors:  Maya Ghoussaini; Paul D P Pharoah
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

2.  Population-based study of familial medullary thyroid cancer.

Authors:  K Hemminki; C Dong
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

Review 3.  The genetic epidemiology of prostate cancer and its clinical implications.

Authors:  Rosalind Eeles; Chee Goh; Elena Castro; Elizabeth Bancroft; Michelle Guy; Ali Amin Al Olama; Douglas Easton; Zsofia Kote-Jarai
Journal:  Nat Rev Urol       Date:  2013-12-03       Impact factor: 14.432

4.  Cancers in the first-degree relatives of children with brain tumours.

Authors:  K Hemminki; X Li; P Vaittinen; C Dong
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

5.  A constant risk for familial breast cancer? A population-based family study.

Authors:  Kamila Czene; Marie Reilly; Per Hall; Mikael Hartman
Journal:  Breast Cancer Res       Date:  2009-05-20       Impact factor: 6.466

6.  Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.

Authors:  Gisela Orozco; Chee L Goh; Ali Amin Al Olama; Sara Benlloch-Garcia; Koveela Govindasami; Michelle Guy; Kenneth R Muir; Graham G Giles; Gianluca Severi; David E Neal; Freddie C Hamdy; Jenny L Donovan; Zsofia Kote-Jarai; Douglas F Easton; Steve Eyre; Rosalind A Eeles
Journal:  BJU Int       Date:  2012-09-18       Impact factor: 5.588

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.